Form D — Salve Therapeutics, Inc.
0002065545-25-000001 · filed 2025-05-02
Offering
- Industry
- Biotechnology
- Exemptions
- 06c
- Total offering
- $687,500
- Total sold
- $12,500
- Minimum investment
- $1,500
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Salve Therapeutics, Inc.
- CIK
- 2065545
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 461 W 6TH ST
SAN PEDRO, CA 90731 - Phone
- 6178944338
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Stefan Nicholas Lukianov · Executive OfficerFRAMINGHAM, MA Find on LinkedIn ↗
View original on SEC EDGAR.